HealthCap Partners — Seed VC Firm ($1.0M–$5.0M Checks)
HealthCap Partners is a Seed venture capital firm based in London, UK investing in Healthcare. The firm typically writes $1.0M–$5.0M checks and has 24 portfolio companies in our records.
- Check size
- $1.0M–$5.0M
- Portfolio
- 24 companies on record
- Partners
- 12 listed
- AUM
- $1.3B
- Stage
- Seed
- Sectors
- Healthcare
- HQ
- London, UK
Last verified: 2026-06-14
Seed
$1.0M – $5.0M
$1.3B
24+ companies
12 partners
About HealthCap Partners
HealthCap Partners is a venture capital firm headquartered in London, UK. The firm focuses on transformative HealthTech innovations, particularly neurotech and digital therapeutics addressing neurological disorders. HealthCap Partners invests at the seed stage across the sectors of healthcare, neurotech, and digital therapeutics with typical check sizes of $1.0M–$5.0M.
The firm has assets under management of $1.3B. Warm introductions are preferred. The team comprises partners with backgrounds in life sciences, therapeutics, drug development, precision medicine, oncology, healthcare, and related fields including legal, M&A, corporate finance, and scientific leadership.
Investment Thesis
Focuses on transformative HealthTech innovations, particularly neurotech and digital therapeutics addressing neurological disorders.
How HealthCap Partners invests
HealthCap Partners is a vc firm based in London, UK. The firm invests at the Seed stage, with a focus on Healthcare.
HealthCap Partners typically writes checks of $1.0M–$5.0M per investment, backed by approximately $1.3B in assets under management.
HealthCap Partners has backed 24 companies in our records, including NeuroFlow, BrainCheck, Emergency Response Africa (ERA).
Partners & Team
Björn Odlander
General Partner
Mårten Steen
Managing Partner
Eugen Steiner
Partner
Industry Focus
Invests In
Recent Activity
Investment Track Record
HealthCap Partners has recorded investments in 24 portfolio companies. The firm has backed a range of healthcare, life sciences, and neurotech companies including AMRA Medical, BrainCheck, NeuroFlow, Neobiomics, and Ultragenyx Pharmaceuticals Inc. Other recorded investments include Emergency Response Africa, Helium Health, MDaaS Global, Tribune Therapeutics AB, Trigen Ltd., Trimb Healthcare AB, Tripep AB, Ultrazonix Holding AB, Vägakuten AB, and Vicore Pharma.
These investments span digital diagnostics, medical imaging, pediatric nutrition, and additional areas within healthcare and life sciences. The firm continues to support early-stage companies developing solutions for neurological disorders and related therapeutic needs.
Portfolio Companies (24)
Other
NeuroFlow
BrainCheck
Emergency Response Africa (ERA)
MDaaS Global
Helium Health
Tribune Therapeutics AB
Trigen Ltd.
Trimb Healthcare AB
Tripep AB
Ultragenyx Pharmaceuticals Inc.
- •Raising at Seed? You're squarely in their sweet spot.
- •Lead with your fit in Healthcare — the sectors they actively back.
- •Size your ask to their typical $1.0M – $5.0M check.
- •warm intro preferred
- •Address your outreach to a specific partner, such as Björn Odlander, General Partner.
- •A warm introduction beats a cold email. Get matched and request an intro.
Featured In
Browse More Investors
Fundraising resources
Frequently Asked Questions
See if HealthCap Partners is a match for your startup
Upload your pitch deck to see how well you match with HealthCap Partners and 10,000+ other investors.
Ask your AI assistant about this investor: connect InvestorMatch to Claude or ChatGPT
Is this your profile? Request a correction or removal